Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Diagnosing peri-implant disease using the tongue as a 24/7 detector

J. Ritzer, T. Lühmann, C. Rode, M. Pein-Hackelbusch, I. Immohr, U. Schedler, T. Thiele, S. Stübinger, BV. Rechenberg, J. Waser-Althaus, F. Schlottig, M. Merli, H. Dawe, M. Karpíšek, R. Wyrwa, M. Schnabelrauch, L. Meinel,

. 2017 ; 8 (1) : 264. [pub] 20170815

Language English Country Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc18016423

Our ability of screening broad communities for clinically asymptomatic diseases critically drives population health. Sensory chewing gums are presented targeting the tongue as 24/7 detector allowing diagnosis by "anyone, anywhere, anytime". The chewing gum contains peptide sensors consisting of a protease cleavable linker in between a bitter substance and a microparticle. Matrix metalloproteinases in the oral cavity, as upregulated in peri-implant disease, specifically target the protease cleavable linker while chewing the gum, thereby generating bitterness for detection by the tongue. The peptide sensors prove significant success in discriminating saliva collected from patients with peri-implant disease versus clinically asymptomatic volunteers. Superior outcome is demonstrated over commercially available protease-based tests in saliva. "Anyone, anywhere, anytime" diagnostics are within reach for oral inflammation. Expanding this platform technology to other diseases in the future features this diagnostic as a massive screening tool potentially maximizing impact on population health.Early detection of gum inflammation caused by dental implants helps prevent tissue damage. Here, the authors present a peptide sensor that generates a bitter taste when cleaved by proteases present in peri-implant disease, embed it in a chewing gum, and compare the probe to existing sensors using patient saliva.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18016423
003      
CZ-PrNML
005      
20180523130812.0
007      
ta
008      
180515s2017 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41467-017-00340-x $2 doi
035    __
$a (PubMed)28811549
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Ritzer, J $u Institute for Pharmacy and Food Chemistry, Universität Würzburg, Am Hubland, 97074, Würzburg, Germany.
245    10
$a Diagnosing peri-implant disease using the tongue as a 24/7 detector / $c J. Ritzer, T. Lühmann, C. Rode, M. Pein-Hackelbusch, I. Immohr, U. Schedler, T. Thiele, S. Stübinger, BV. Rechenberg, J. Waser-Althaus, F. Schlottig, M. Merli, H. Dawe, M. Karpíšek, R. Wyrwa, M. Schnabelrauch, L. Meinel,
520    9_
$a Our ability of screening broad communities for clinically asymptomatic diseases critically drives population health. Sensory chewing gums are presented targeting the tongue as 24/7 detector allowing diagnosis by "anyone, anywhere, anytime". The chewing gum contains peptide sensors consisting of a protease cleavable linker in between a bitter substance and a microparticle. Matrix metalloproteinases in the oral cavity, as upregulated in peri-implant disease, specifically target the protease cleavable linker while chewing the gum, thereby generating bitterness for detection by the tongue. The peptide sensors prove significant success in discriminating saliva collected from patients with peri-implant disease versus clinically asymptomatic volunteers. Superior outcome is demonstrated over commercially available protease-based tests in saliva. "Anyone, anywhere, anytime" diagnostics are within reach for oral inflammation. Expanding this platform technology to other diseases in the future features this diagnostic as a massive screening tool potentially maximizing impact on population health.Early detection of gum inflammation caused by dental implants helps prevent tissue damage. Here, the authors present a peptide sensor that generates a bitter taste when cleaved by proteases present in peri-implant disease, embed it in a chewing gum, and compare the probe to existing sensors using patient saliva.
650    12
$a žvýkačka $7 D002638
650    12
$a zubní implantáty $7 D015921
650    _2
$a gingivitida $x diagnóza $x metabolismus $7 D005891
650    _2
$a lidé $7 D006801
650    _2
$a matrixové metaloproteinasy $x metabolismus $7 D020782
650    _2
$a peptidy $x metabolismus $7 D010455
650    _2
$a parodontitida $x diagnóza $x metabolismus $7 D010518
650    _2
$a sliny $x enzymologie $7 D012463
650    12
$a chuť $7 D013649
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Lühmann, T $u Institute for Pharmacy and Food Chemistry, Universität Würzburg, Am Hubland, 97074, Würzburg, Germany.
700    1_
$a Rode, C $u Biomaterials Department, Innovent e.V., Prüssingstraße 27B, 07745, Jena, Germany.
700    1_
$a Pein-Hackelbusch, M $u Institute for Pharmaceutics, Universität Düsseldorf, Universitätsstraße 1, 40225, Düsseldorf, Germany.
700    1_
$a Immohr, I $u Institute for Pharmaceutics, Universität Düsseldorf, Universitätsstraße 1, 40225, Düsseldorf, Germany.
700    1_
$a Schedler, U $u PolyAn GmbH, Rudolf-Baschant-Straße 2, 13086, Berlin, Germany.
700    1_
$a Thiele, T $u PolyAn GmbH, Rudolf-Baschant-Straße 2, 13086, Berlin, Germany.
700    1_
$a Stübinger, S $u Musculoskeletal Research Unit, Center for Applied Biotechnology and Molecular Medicine, Universität Zürich, Winterthurerstrasse 270, 8057, Zurich, Switzerland.
700    1_
$a Rechenberg, B V $u Musculoskeletal Research Unit, Center for Applied Biotechnology and Molecular Medicine, Universität Zürich, Winterthurerstrasse 270, 8057, Zurich, Switzerland.
700    1_
$a Waser-Althaus, J $u Thommen Medical AG, Neckarsulmstrasse 28, 2540, Grenchen, Switzerland.
700    1_
$a Schlottig, F $u Thommen Medical AG, Neckarsulmstrasse 28, 2540, Grenchen, Switzerland.
700    1_
$a Merli, M $u Indent-International Dental Research and Education srl, Via Settembrini 17/o, 47923, Rimini, Italy.
700    1_
$a Dawe, H $u Indent-International Dental Research and Education srl, Via Settembrini 17/o, 47923, Rimini, Italy.
700    1_
$a Karpíšek, M $u BioVendor-Laboratorni medicina AS and Department of Human Pharmacology and Toxicology, University of Veterinary and Pharmaceutical Sciences, Palackého 1-3, 61242, Brno, Czech Republic.
700    1_
$a Wyrwa, R $u Biomaterials Department, Innovent e.V., Prüssingstraße 27B, 07745, Jena, Germany.
700    1_
$a Schnabelrauch, M $u Biomaterials Department, Innovent e.V., Prüssingstraße 27B, 07745, Jena, Germany.
700    1_
$a Meinel, L $u Institute for Pharmacy and Food Chemistry, Universität Würzburg, Am Hubland, 97074, Würzburg, Germany. lorenz.meinel@uni-wuerzburg.de.
773    0_
$w MED00184850 $t Nature communications $x 2041-1723 $g Roč. 8, č. 1 (2017), s. 264
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28811549 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180515 $b ABA008
991    __
$a 20180523130957 $b ABA008
999    __
$a ok $b bmc $g 1300047 $s 1013263
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 8 $c 1 $d 264 $e 20170815 $i 2041-1723 $m Nature communications $n Nat Commun $x MED00184850
LZP    __
$a Pubmed-20180515

Find record

Citation metrics

Archiving options